Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel

Phase 2 Terminated 40 enrolled Geriatric Oncology Consortium Sanofi · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is to explore the feasibility of an alternative dose of dexamethasone pre-medication in older breast and lung cancer patients who are receiving weekly docetaxel chemotherapy.

Timeline

Start: 2004-08
Primary completion: —
Completion: 2007-04

Outcome

Outcome not reported

Stopped (Enrollment): “slow accrual”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dexamethasone	Small molecule	—	Oral

Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel

Summary

Timeline

Outcome

Drugs

Indications